Search

Search Constraints

You searched for: Author/Creator Dobbelaere, Dries

Search Results

11. Impact of the SARS‐CoV‐2 pandemic on the health of individuals with intoxication‐type metabolic diseases—Data from the E‐IMD consortium. Issue 2 (14th November 2022)

12. Long term outcome of MPI‐CDG patients on D‐mannose therapy. Issue 6 (9th August 2020)

13. Mitochondrial acetoacetyl‐CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis. Issue 3 (2nd March 2017)

15. Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver–derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients. Issue 9 (September 2019)

16. Position statement on the role of healthcare professionals, patient organizations and industry in European Reference Networks. Issue 1 (December 2016)

18. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. Issue 6 (15th April 2015)

19. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. Issue 6 (15th April 2015)

20. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders—A successful strategy for clinical research of rare diseases. Issue 1 (11th February 2019)